Page last updated: 2024-10-25

clioquinol and Intellectual Disability

clioquinol has been researched along with Intellectual Disability in 2 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LACNY, J1
BATTERMAN, RC1
GHOLZ, LM1
BELL, ME1

Other Studies

2 other studies available for clioquinol and Intellectual Disability

ArticleYear
Management, treatment and prevention of bacillary dysentery among the mentally retarded patients.
    Applied therapeutics, 1961, Volume: 3

    Topics: Amebicides; Bacillus; Clioquinol; Dysentery; Dysentery, Bacillary; Gram-Positive Bacteria; Humans; I

1961
STABILITY OF BACTERIAL FLORA WITH LONG-TERM IODOCHLORHYDROXYQUIN THERAPY.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 115

    Topics: Child; Clioquinol; Down Syndrome; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Enterob

1964